Bill Desmarais is the Chief Business Officer at TScan Therapeutics.  He brings 20 years of experience in the biotechnology and pharmaceutical industry.  Prior to joining TScan, Bill served as the Vice President of Business Development at Momenta Pharmaceuticals where he led much of the partnering efforts until Momenta’s merger with Janssen Pharmaceuticals.  Before joining Momenta, Bill held multiple roles at Eli Lilly and Company in external innovation and business development.

He has a PhD in Biophysics and Structural Biology from Brandeis University, an MBA in General Management from MIT’s Sloan School of Management, and a BS in Cell and Developmental Biology from Purdue University.  He is a veteran of the U.S. Army. When he is away from TScan, Bill can be found camping with the Boy Scouts, rappelling with the United States Naval Sea Cadets Corps, mentoring entrepreneurs, or taking care of his beehives with his children.